Accelerate Diagnostics Inc (AXDX)
1.35
+0.01
(+0.75%)
USD |
NASDAQ |
Jun 14, 16:00
1.31
-0.04
(-2.96%)
After-Hours: 20:00
Accelerate Diagnostics Research and Development Expense (Quarterly): 5.173M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.173M |
| December 31, 2023 | 5.57M |
| September 30, 2023 | 6.996M |
| June 30, 2023 | 5.82M |
| March 31, 2023 | 6.968M |
| December 31, 2022 | 6.03M |
| September 30, 2022 | 7.285M |
| June 30, 2022 | 7.576M |
| March 31, 2022 | 6.024M |
| December 31, 2021 | 4.602M |
| September 30, 2021 | 4.712M |
| June 30, 2021 | 5.733M |
| March 31, 2021 | 6.895M |
| December 31, 2020 | 5.064M |
| September 30, 2020 | 5.001M |
| June 30, 2020 | 5.347M |
| March 31, 2020 | 5.842M |
| December 31, 2019 | 6.20M |
| September 30, 2019 | 6.064M |
| June 30, 2019 | 6.149M |
| March 31, 2019 | 6.933M |
| December 31, 2018 | 6.904M |
| September 30, 2018 | 7.891M |
| June 30, 2018 | 6.06M |
| March 31, 2018 | 6.782M |
| Date | Value |
|---|---|
| December 31, 2017 | 6.135M |
| September 30, 2017 | 6.351M |
| June 30, 2017 | 5.527M |
| March 31, 2017 | 4.288M |
| December 31, 2016 | 5.59M |
| September 30, 2016 | 7.874M |
| June 30, 2016 | 8.425M |
| March 31, 2016 | 7.675M |
| December 31, 2015 | 7.786M |
| September 30, 2015 | 6.499M |
| June 30, 2015 | 7.126M |
| March 31, 2015 | 5.73M |
| December 31, 2014 | 5.452M |
| September 30, 2014 | 5.949M |
| June 30, 2014 | 4.562M |
| March 31, 2014 | 3.564M |
| December 31, 2013 | 3.677M |
| September 30, 2013 | 2.655M |
| June 30, 2013 | 2.461M |
| March 31, 2013 | 1.882M |
| October 31, 2012 | 0.5642M |
| July 31, 2012 | 0.1291M |
| April 30, 2012 | 0.1099M |
| January 31, 2012 | 0.0889M |
| October 31, 2011 | 0.1042M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.602M
Minimum
Dec 2021
7.576M
Maximum
Jun 2022
5.952M
Average
5.933M
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp | 81.80M |
| Achieve Life Sciences Inc | 2.799M |
| ENDRA Life Sciences Inc | 1.042M |
| Tivic Health Systems Inc | 0.256M |
| Spectral AI Inc | -- |